La flecaïnide : un médicament inducteur de lupus ?
G. Pugnet(Hôpital Rangueil), L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), Martin Michaud(Centre Hospitalier Universitaire de Toulouse), L. Astudillo(Hôpital Purpan), M. Forgues(Hôpital Purpan), Haleh Bagheri(Université Fédérale de Toulouse Midi-Pyrénées), J L Montastruc(Observatoire Midi-Pyrénées), P. Arlet(Hôpital Rangueil)
Cited by 0
Related Papers
Proinflammatory Cytokines, Aging, and Age-Related Diseases
|Journal of the American Medical Directors Association|2013|1.1k
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
SPECT imaging of striatal pre- and postsynaptic dopaminergic status in restless legs syndrome with periodic leg movements in sleep
|Journal of Neurology|2002|277
Periodic leg movements in REM sleep behavior disorder and related autonomic and EEG activation
|Neurology|2002|249
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207